INS 2022: Occipital nerve stimulation shows clinical benefit and safety in chronic cluster headache
A randomised controlled trial (RCT) presented at the International Neuromodulation Society (INS) congress (21–26 May 2022, Barcelona, Spain) has demonstrated significant and clinically relevant...
Multisession tDCS alongside cognitive remediation promotes social functioning in autism patients
In a randomised, sham-controlled clinical trial, multisession transcranial direct current stimulation (tDCS) paired with concurrent cognitive remediation training has been shown to promote social...
INS 2022: Dorsal horn dendrite stimulation offers “true breakthrough” in pain management field
A novel approach to spinal cord stimulation (SCS), which involves targeting the dorsal horn dendrite—in contrast with more traditional ‘axonal’ SCS techniques—has been labelled...
Neuromodulation for post-stroke recovery advancing on several fronts
As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...
